Conversely, modulation of angiogenic pathways by chemoradiotherapy, as observed in the present study through reductions in VEGF-C and HB-EGF and PCA-driven clustering of survival-associated profiles, may reprogram the tumor microenvironment into a more immune-permissive state. Here, HBEGF is linked to neoplasm.